Skip to main content

Table 1 The list of 31 different cancer types under investigation, indicating the acronyms and the sample numerosity for each cancer type and for each corresponding control

From: Analysis of gene expression levels and their impact on survival in 31 cancer-types patients identifies novel prognostic markers and suggests unexplored immunotherapy treatment options in a wide range of malignancies

Acronym

Cancer type

N. of tumor samples

N. of normal samples

ACC

Adrenocortical carcinoma

77

128

BLCA

Bladder Urothelial Carcinoma

404

28

BRCA

Breast invasive carcinoma

1085

291

CESC

Cervical squamous cell carcinoma and endocervical adenocarcinoma

306

13

CHOL

Cholangiocarcinoma

36

9

COAD

Colon adenocarcinoma

275

349

DLBC

Lymphoid Neoplasm Diffuse Large B-cell Lymphoma

47

337

ESCA

Esophageal carcinoma

182

286

GBM

Glioblastoma multiforme

163

207

HNSC

Head and Neck squamous cell carcinoma

519

44

KICH

Kidney Chromophobe

66

53

KIRC

Kidney renal clear cell carcinoma

523

100

KIRP

Kidney renal papillary cell carcinoma

286

60

LAML

Acute Myeloid Leukemia

173

70

LGG

Brain Lower Grade Glioma

518

207

LIHC

Liver hepatocellular carcinoma

369

160

LUAD

Lung adenocarcinoma

483

347

LUSC

Lung squamous cell carcinoma

486

338

OV

Ovarian serous cystadenocarcinoma

426

88

PAAD

Pancreatic adenocarcinoma

179

171

PCPG

Pheochromocytoma and Paraganglioma

182

3

PRAD

Prostate adenocarcinoma

492

152

READ

Rectum adenocarcinoma

92

318

SARC

Sarcoma

262

2

SKCM

Skin Cutaneous Melanoma

461

558

STAD

Stomach adenocarcinoma

408

211

TGCT

Testicular Germ Cell Tumors

137

165

THCA

Thyroid carcinoma

512

337

THYM

Thymoma

118

339

UCEC

Uterine Corpus Endometrial Carcinoma

174

91

UCS

Uterine Carcinosarcoma

57

78

 

Totals

9498

5540